Common use of SUPPLEMENTAL INDENTURES WITHOUT Clause in Contracts

SUPPLEMENTAL INDENTURES WITHOUT. The Consent Of Securityholders 27 Section 9.02 Supplemental Indentures With Consent Of Securityholders 27 Section 9.03 Effect Of Supplemental Indentures 28 Section 9.04 Securities Affected By Supplemental Indentures 28 Section 9.05 Execution Of Supplemental Indentures 28 ARTICLE 10 SUCCESSOR ENTITY 29 Section 10.01 Company May Consolidate, Etc. 29 Section 10.02 Successor Entity Substituted 29 ARTICLE 11 SATISFACTION AND DISCHARGE 29 Section 11.01 Satisfaction And Discharge Of Indenture 29 Section 11.02 Discharge Of Obligations 30 Section 11.03 Deposited Moneys To Be Held In Trust 30 Section 11.04 Payment Of Moneys Held By Paying Agents 30 Section 11.05 Repayment To Company 30 ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS 31 Section 12.01 No Recourse 31 Page ARTICLE 13 MISCELLANEOUS PROVISIONS 31 Section 13.01 Effect On Successors And Assigns 31 Section 13.02 Actions By Successor 31 Section 13.03 Surrender Of Company Powers 31 Section 13.04 Notices 31 Section 13.05 Governing Law 32 Section 13.06 Treatment Of Securities As Debt 32 Section 13.07 Certificates And Opinions As To Conditions Precedent 32 Section 13.08 Payments On Business Days 32 Section 13.09 Conflict With Trust Indenture Act 32 Section 13.10 Counterparts 32 Section 13.11 Separability 33 Section 13.12 Compliance Certificates 33

Appears in 3 contracts

Samples: Ardea Biosciences, Inc./De, Sequenom Inc, Sequenom Inc

AutoNDA by SimpleDocs

SUPPLEMENTAL INDENTURES WITHOUT. The Consent Of Securityholders 27 of Noteholders 44 Section 9.02 11.02. Supplemental Indentures With Consent Of Securityholders 27 of Noteholders 45 Section 9.03 11.03. Effect Of of Supplemental Indentures 28 46 Section 9.04 Securities Affected By 11.04. Notation on Notes 46 Section 11.05. Evidence of Compliance of Supplemental Indentures 28 Indenture to Be Furnished to Trustee 46 ARTICLE 12 CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE Section 9.05 Execution Of Supplemental Indentures 28 ARTICLE 10 SUCCESSOR ENTITY 29 Section 10.01 12.01. Company May Consolidate, Etc. 29 46 Section 10.02 12.02. Successor Entity Corporation to Be Substituted 29 47 Section 12.03. Opinion of Counsel to Be Given to Trustee 47 ARTICLE 11 SATISFACTION AND DISCHARGE 29 Section 11.01 Satisfaction And Discharge Of Indenture 29 Section 11.02 Discharge Of Obligations 30 Section 11.03 Deposited Moneys To Be Held In Trust 30 Section 11.04 Payment Of Moneys Held By Paying Agents 30 Section 11.05 Repayment To Company 30 ARTICLE 12 13 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS 31 Section 12.01 No Recourse 31 13.01. Indenture and Notes Solely Corporate Obligations 48 ARTICLE 14 [INTENTIONALLY OMITTED] ARTICLE 15 CONVERSION OF NOTES Section 15.01. Conversion Privilege 48 Section 15.02. Conversion Procedure 50 Section 15.03. Increased Conversion Rate Applicable to Certain Notes Surrendered in Connection with Make-Whole Fundamental Changes 53 Section 15.04. Adjustment of Conversion Rate 55 Section 15.05. Shares to Be Fully Paid 64 Section 15.06. Effect of Reclassification, Consolidation, Merger or Sale 65 Section 15.07. Certain Covenants 67 Page Section 15.08. Responsibility of Trustee 67 Section 15.09. Notice to Noteholders Prior to Certain Actions 68 Section 15.10. Stockholder Rights Plans 69 Section 15.11. Exchange in Lieu of Conversion 69 ARTICLE 13 16 REPURCHASE OF NOTES AT OPTION OF HOLDERS Section 16.01. [Reserved] 69 Section 16.02. Repurchase at Option of Noteholders upon a Fundamental Change 69 Section 16.03. Withdrawal of Fundamental Change Repurchase Notice 72 Section 16.04. Deposit of Fundamental Change Repurchase Price 73 ARTICLE 17 MISCELLANEOUS PROVISIONS 31 Section 13.01 Effect On 17.01. Provisions Binding on Company’s Successors And Assigns 31 73 Section 13.02 Actions By 17.02. Official Acts by Successor 31 Corporation 73 Section 13.03 Surrender Of Company Powers 31 17.03. Addresses for Notices, Etc. 74 Section 13.04 Notices 31 Section 13.05 17.04. Governing Law 32 74 Section 13.06 Treatment Of Securities As Debt 32 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 74 Section 13.07 Certificates And Opinions As To Conditions Precedent 32 17.06. Legal Holidays 75 Section 13.08 Payments On Business Days 32 17.07. No Security Interest Created 75 Section 13.09 Conflict With 17.08. Benefits of Indenture 75 Section 17.09. Table of Contents, Headings, Etc. 75 Section 17.10. Authenticating Agent 75 Section 17.11. Execution in Counterparts 76 Section 17.12. Severability 76 Section 17.13. Waiver of Jury Trial 76 Section 17.14. Force Majeure 77 EXHIBITS Exhibit A Form of Note A-1 Exhibit B Form of Notice of Conversion B-1 Exhibit C Form of Fundamental Change Repurchase Notice C-1 Exhibit D Form of Assignment and Transfer D-1 INDENTURE dated as of July 29, 2008 between Alliance Data Systems Corporation, a Delaware corporation, as issuer (the “Company”) and The Bank of New York Mellon Trust Indenture Act 32 Section 13.10 Counterparts 32 Section 13.11 Separability 33 Section 13.12 Compliance Certificates 33Company, National Association, as trustee (the “Trustee”).

Appears in 1 contract

Samples: Alliance Data Systems Corp

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.